Skip to evidence report

MAC.MDM.complement_resolving: Studies — page 3

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,931 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 2,001–3,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for MAC.MDM.complement_resolving
#Trait / studyIndividual trait IDMean IC score
2001Biological Grandparent (maternal): Alzheimer's / Other DementiaGCST904754848.72
2002Irritable bowel syndrome mixed subtypeGCST902439598.71
2003CD63/EDAR ratioGCST903138648.71
2004Ratio of polyunsaturated fatty acids to monounsaturated fatty acidsGCST900929408.71
2005Parkinson's diseaseFING000011508.70
2006CLEC4D/CLEC6A ratioGCST903141098.69
2007EIF4G1/HEXIM1 ratioGCST903146358.69
2008SNAP29/SPARC ratioGCST903158608.68
2009Cholesteryl Esters in Small HDLGCST904993828.68
2010LEPR levelsGCST904697568.67
2011Frequency of light DIY in last 4 weeks | Physical activityUKBB000002648.67
2012F-dessert liking (derived food-liking factor)GCST900947548.66
2013SNAP23/TBL1X ratioGCST903158568.65
2014Abdominal subcutaneous adipose tissue normalizedGCST902673488.65
2015BCAN/NPTXR ratioGCST903134828.64
2016TFPI levelsGCST904708398.64
2017Seronegative rheumatoid arthritisFING000012968.64
2018PlateletcritGCST0046078.64
2019SIT1 levelsGCST904706448.64
2020GDI2 levelsGCST900880048.64
2021SPARC/ZBTB16 ratioGCST903158758.63
2022Phospholipids to total lipids ratio in large VLDLGCST900928778.63
2023ANGPT1/PDGFA ratioGCST903132668.62
2024KITLG/PLTP ratioGCST903152528.61
2025wg rh intensity-contrast temporalpoleGCST900038598.60
2026Basophil percentage of white cellsGCST0046318.59
2027IDP T1 FAST ROIs L cerebellum I-IVGCST900025628.59
2028ANGPT1/EGF ratioGCST903132648.59
2029ECE1 levelsGCST904690618.59
2030MYO9B levelsGCST904699828.59
2031T1 FreeSurfer a2009s lh S central thicknessGCST903847868.58
2032MYOM3 levelsGCST904699868.58
2033Speech-in-noise perceptionGCST900447768.58
2034Oranges likingGCST900948078.58
2035Follicular cysts of skin and subcutaneous tissueFING000005478.58
2036GRN levelsGCST904694048.56
2037PTPN1/WWP2 ratioGCST903157468.56
2038HPCAL1/MPIG6B ratioGCST903150738.55
2039CD58/ROR1 ratioGCST903138548.55
2040Treatment/medication code - ibuprofen | MedicationsUKBB000008478.55
2041IGF1 levelsGCST901026238.55
2042CCN2/HBEGF ratioGCST903137138.54
2043OMD/SPP1 ratioGCST903155868.54
2044MMP8/OLR1 ratioGCST903154648.54
2045DDX58 levelsGCST904689778.53
2046BSG/LAMP3 ratioGCST903135338.53
2047Free cholesterol in IDLGCST904975618.53
2048BST2/CEACAM1 ratioGCST903135378.52
2049Cholesterol esters in very small VLDLGCST905007498.50
2050RNASE1 levelsGCST904704768.50
2051Omega-6 fatty acid levelsGCST905025188.50
2052Monounsaturated fatty acid levelsGCST905023588.49
20531-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levelsGCST902006858.49
2054CST3/IL18BP ratioGCST903142948.48
2055NPTX1 levelsGCST904700788.47
2056FKBP4/WWP2 ratioGCST903148428.47
2057HDL x anxiety interaction (2df test)GCST905706658.47
2058ABL1/DNMBP ratioGCST903131498.47
2059Blood cell traits latent factor 5 (platelet)GCST905592478.45
2060HBEGF/SDC4 ratioGCST903150378.45
2061AXIN1/NFATC1 ratioGCST903134158.45
2062ECHS1 levelsGCST904690638.45
2063Ingrowing nail (PheCode 703.1)GCST904762088.45
2064Reason for reducing amount of alcohol drunk - Other reason | AlcoholUKBB000007358.44
2065Ulcerative ileocolitisFING000013928.44
2066Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905025548.43
2067FHIT/PMVK ratioGCST903148228.43
2068Neutrophils and lymphocytes in blood (confirmatory factor analysis Factor 35)GCST903093698.42
2069Triglycerides to total lipids ratio in medium VLDLGCST900929278.42
2070Chronic ulcer of leg or foot (PheCode 707.2)GCST904762188.42
2071Chronic diseases of tonsils and adenoidsFING000002838.41
2072IL17A levelsGCST904695588.39
2073Types of physical activity in last 4 weeks - Strenuous sports | Physical activityUKBB000008748.39
2074FCER2/TCL1A ratioGCST903147908.39
2075IDP dMRI TBSS ICVF Tapetum LGCST900043748.39
2076ITGB1BP2 levelsGCST900120588.38
2077LAIR2 levelsGCST904697298.38
2078ADH4/DCXR ratioGCST903131908.38
2079DPP7 levelsGCST904690358.37
2080TGFBR2/TNFRSF1A ratioGCST903159188.37
2081Phospholipids in VLDLGCST905002688.37
2082LMNB1 levelsGCST904697818.35
2083MVK/SERPINE1 ratioGCST903155058.34
2084Total lipids in lipoprotein particles (UKB data field 23423)GCST902695208.34
2085DTI TBSS L2 Posterior corona radiata RGCST903845028.33
2086Postinfectious hypothyroidismFING000011928.33
2087Bone marrow fat fraction of thoracic vertebra 8GCST906523808.33
2088SERPINB1/TMSB10 ratioGCST903158308.33
2089WASHC3 levelsGCST904710698.32
2090Phenylalanine levelsGCST904992288.31
2091Linoleic acid to total fatty acids percentageGCST905023208.31
2092IDP T1 FAST ROIs V cerebellum VIIIaGCST900025798.30
2093Platelet crit | Blood countUKBB000006478.30
2094Phospholipids to total lipids ratio in medium LDLGCST900929138.30
2095C2/LILRB4 ratioGCST903135548.30
2096MSRA/SNAP29 ratioGCST903155008.29
2097COMP/MYOC ratioGCST903141918.29
2098CEACAM8 levelsGCST904686988.29
2099CXCL5/SDC4 ratioGCST903143538.29
2100MSTN levelsGCST904699538.29
2101Total lipids in small VLDLGCST904998498.28
2102Aspartate aminotransferase levelsGCST900187248.28
2103Polyunsaturated fatty acid levelsGCST905026228.27
2104ITGB5/S100A4 ratioGCST903152338.27
2105Phosphatidylcholine_32:0_[M+H]1+/Phosphatidylethanolamine_35:0_[M+H]1+/Phosphatidate_37:1_[M+NH4]1+ levelsGCST900602708.27
2106SCARF2/TNFRSF21 ratioGCST903158138.27
2107LAMA4/NID1 ratioGCST903152728.26
2108FGF23 levelsGCST900120228.26
2109BACH1/CNST ratioGCST903134368.25
2110Other systemic involvement of connective tissue (FG)FING000011168.23
2111PCDH9 levelsGCST904701728.23
2112T1 FreeSurfer DK lh superiortemporal thicknessGCST903856518.23
2113ADGRG2/NRCAM ratioGCST903131868.21
2114IL18 levelsGCST904695678.21
2115ASAH2 levelsGCST902420988.20
2116Phosphatidylcholine_34:3_[M+H]1+/Phosphatidylethanolamine_37:3_[M+H]1+/Phosphatidate_39:4_[M+NH4]1+ levelsGCST900602988.20
2117CTSC/PLA2G15 ratioGCST903143118.20
2118CD38/RELT ratioGCST903138098.19
2119SSC4D/TNFSF10 ratioGCST903158878.19
2120BMP6 levelsGCST904684548.19
2121Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020698.18
2122CD93/TNFRSF4 ratioGCST903139228.18
2123NFASC levelsGCST904700318.18
2124SUGT1/TBL1X ratioGCST903158978.17
2125DAB2/ZBTB16 ratioGCST903143708.15
2126IDP dMRI ProbtrackX ICVF atr rGCST900043788.14
2127F11R/PLXNA4 ratioGCST903147248.14
2128Fibrosis and cirrhosis of liverFING000005438.14
2129Illness, injury, bereavement, stress in last 2 years - None of the above | Mental healthUKBB000003398.14
2130SERPINE1/USP8 ratioGCST903158358.13
2131Presence of cardiac and vascular implants and grafts | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000007088.13
2132Stable angina pectorisGCST900186958.13
2133ATP5IF1/HSPA1A ratioGCST903133888.12
2134SPRY2/YTHDF3 ratioGCST903158818.12
2135Length of working week for main job | EmploymentUKBB000004058.12
2136Disorders of skin appendagesFING000004608.11
2137aparc-a2009s lh volume G-pariet-inf-SupramarGCST900029508.10
2138IL1R1 levelsGCST904255638.09
2139MMP3 levelsGCST900120278.09
2140AIFM1/SIRT2 ratioGCST903132218.08
2141Free cholesterol levels in VLDLGCST900929988.08
2142Asthma mixed form (mode) (more control exclusions)FING000001168.07
2143Degree of unsaturationGCST905001758.06
2144NUCB2/TRIAP1 ratioGCST903155778.05
2145WARS levelsGCST904710668.05
2146IDP T1 FAST ROIs R cerebellum VIIIaGCST900025808.05
2147SOD3 levelsGCST904707068.05
2148LCN2/PGLYRP1 ratioGCST903153068.04
2149BCL2L11/VASH1 ratioGCST903134858.02
2150Etiocholanolone glucuronide levelsGCST901999648.02
2151LBR/LGALS8 ratioGCST903152948.02
2152CLIP2/DAB2 ratioGCST903141248.01
2153BTN2A1/SMOC2 ratioGCST903135498.01
2154ICA1/MVK ratioGCST903151088.01
2155CLEC1B/DKK1 ratioGCST903140888.00
2156CCDC80 levelsGCST904685628.00
2157FCRL5/ICAM3 ratioGCST903148028.00
2158CALCA levelsGCST904685288.00
2159SERPINA7 levelsGCST904705877.99
2160HSPA1A/MGLL ratioGCST903150837.99
2161PCDH1/TNFRSF11A ratioGCST903156087.99
2162TREML2 levelsGCST904709627.98
2163ALCAM/NOTCH1 ratioGCST903132417.98
2164Omega-6 fatty acids to total fatty acids percentageGCST905025447.96
2165CD48 levelsGCST904256767.96
2166Prescriptions - gliclazide | sulfonylurea,diabetesUKBB000006847.96
2167AKT1S1/MAX ratioGCST903132307.95
2168ANXA4/CA13 ratioGCST903132907.95
2169Cholelithiasis | Disorders of gallbladder, biliary tract and pancreasUKBB000001327.95
2170DSC2/EFEMP1 ratioGCST903145557.94
2171GADD45GIP1 levelsGCST904692937.93
2172FBP1/GSTA1 ratioGCST903147867.92
2173Saturated fatty acids levelsGCST905026707.91
2174STK11/USP8 ratioGCST903158927.91
2175PEAR1/TREML2 ratioGCST903156457.91
2176Alanine transaminase (ALT, mean, inv-norm transformed)GCST904751127.91
2177MSRA/PRDX5 ratioGCST903154977.89
2178Diacylglycerol_36:4_[M+H-H2O]1+ levelsGCST900601887.88
2179POSTN levelsGCST904702887.88
2180Liver volume (adjusted for height)GCST905668197.87
2181HyperlipidemiaGCST900909947.87
2182Phospholipids to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23579)GCST902696767.87
2183FGF2/HBEGF ratioGCST903148117.86
2184CXCL1 levelsGCST900120197.86
2185GanglionFING000005637.85
2186PDGFB/SNAP29 ratioGCST903156277.85
2187Urine X-24798 levels in chronic kidney diseaseGCST902668027.84
2188CLU levelsGCST904687937.84
2189CREG1/NAAA ratioGCST903142507.83
2190ITGB1/VASN ratioGCST903152327.83
2191Alanine transaminase (ALT, minimum, inv-norm transformed)GCST904751157.82
2192Degree of unsaturationGCST905022337.82
2193ADAM8 levelsGCST904682207.81
2194Cholesterol, totalGCST0022217.80
2195CASP3/LYN ratioGCST903136357.80
2196SEMA4C levelsGCST904705727.79
2197Ulcerative colitisGCST904760677.78
2198ENTPD6 levelsGCST904691227.78
2199TXNRD1 levelsGCST904709947.77
2200Retrobulbar neuritis in diseases classified elsewhereFING000012657.77
2201FLT1/TGFB1 ratioGCST903148577.75
2202F11R levelsGCST904691647.75
2203Volume of right paralaminar nucleusGCST904750487.74
2204FCRL5 levelsGCST904692087.74
2205CLEC1B/HBEGF ratioGCST903140927.73
2206NeuroticismGCST0029207.72
2207CD22/TCL1A ratioGCST903137607.72
2208F2R/TMSB10 ratioGCST903147387.72
2209KLK6/MOG ratioGCST903152557.71
2210CCL3 levelsGCST900120557.69
2211IFNGR1/IL10RB ratioGCST903151277.69
2212DTI autoptx MD unc r tractGCST903852467.67
2213Docosahexaenoic acid to total fatty acids percentageGCST905022857.67
2214aseg lh volume CerebralWhiteMatterGCST900026157.66
2215FAM174A levelsGCST902419147.66
2216Lymphocyte percentage of white cellsGCST900023897.66
2217ITGAV levelsGCST904696397.65
2218Polyunsaturated fatty acids to saturated fatty acids ratioGCST905021687.64
2219CRTAM/GZMA ratioGCST903142757.64
2220Other disorders of stomach and duodenum (PheCode 537)GCST904760547.63
2221LGALS8/VWF ratioGCST903153227.62
2222PGD levelsGCST904702177.62
2223CEP43/WASF1 ratioGCST903140237.61
2224Fractured/broken bones in last 5 years | Medical conditionsUKBB000002587.60
2225EXTL1 levelsGCST904691617.60
2226CD84/GP1BA ratioGCST903139137.59
2227ERP44/SUMF2 ratioGCST903147107.59
2228EFHD1 levelsGCST904690797.58
2229RGMB/TNFRSF21 ratioGCST903157727.58
2230CD2AP/USP8 ratioGCST903137847.57
2231aseg rh volume CerebralWhiteMatterGCST900026327.56
2232Osteoporosis NOS (PheCode 743.11)GCST904762607.56
2233Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606)GCST902697037.56
2234CTSH levelsGCST904689137.56
2235CLEC3B levelsGCST904687707.55
2236HPCAL1/NUDC ratioGCST903150747.55
2237ENO3 levelsGCST904691117.54
2238PODXL2/SEZ6L ratioGCST903157027.53
2239CD58/IL10RB ratioGCST903138507.52
2240CD40/ITGB5 ratioGCST903138167.51
2241Medication use (immunosuppressants)GCST900187717.51
2242DAG1/PDGFA ratioGCST903143787.51
2243PON3 levelsGCST904702877.51
2244Acute peritonitisFING000000287.49
2245NXF1 levelsGCST902421497.49
2246Cholesteryl Esters to Total Lipids in Medium VLDL percentageGCST904989567.47
2247NUDT5/TXNRD1 ratioGCST903155827.47
2248SDC4/WWP2 ratioGCST903158217.47
2249Gamma-CEHC levelsGCST901998647.46
2250LAT/VASH1 ratioGCST903152897.45
2251aseg rh volume Cerebellum-White-MatterGCST900026357.45
2252CD69/NFATC1 ratioGCST903138797.45
2253ICA1/YTHDF3 ratioGCST903151137.45
2254Treatment or medication use - ezetimibe (UKB data field 20003_1141192736)GCST900425417.44
2255CDKN1A/DAB2 ratioGCST903139677.44
2256Principal component-derived dietary pattern 58GCST901330617.44
2257Free cholesterol in large VLDLGCST904981817.44
2258EDAR/IPCEF1 ratioGCST903145787.44
2259CLEC1B/GP1BA ratioGCST903140917.44
2260Cholesteryl ester (16:2) levelsGCST900246287.44
2261APP/HBEGF ratioGCST903133247.44
2262Total cholesterol levelsGCST900187547.43
2263FABP2/RBP2 ratioGCST903147577.43
2264DAB2/VASH1 ratioGCST903143697.42
2265Sphingomyelins levelsGCST904999727.42
2266MESD/NCK2 ratioGCST903154217.41
2267CEP43/USP8 ratioGCST903140227.41
2268TBCB/TBCC ratioGCST903159097.41
2269lymphocyte (fraction, minimum, inv-norm transformed)GCST904754387.41
2270CXCL17/LAMP3 ratioGCST903143407.40
2271Omega-6 fatty acids to total fatty acids percentageGCST905025457.39
2272RadiculopathyFING000012387.39
2273Inflammatory bowel disease, strict (require KELA)FING000006757.39
2274CEP170 levelsGCST904687117.39
2275CREG1/SMPDL3A ratioGCST903142527.39
22761-ribosyl-imidazoleacetate levelsGCST901998157.39
2277Gout, unspecifiedFING000005897.39
2278EGFL7 levelsGCST904690837.38
2279F2R/SERPINE1 ratioGCST903147357.38
2280Prescriptions - opioid analgesic|selective serotonin re-uptake inhibitor|norepinephrine re-uptake inhibitorUKBB000006947.38
2281Prescriptions - tramadol | opioid analgesic,selective serotonin re-uptake inhibitor,norepinephrine re-uptake inhibitorUKBB000007067.38
2282Sleep apnea | neurologicalUKBB000007747.37
2283Concentration of IDL particlesGCST904976067.37
2284Other haemoglobinopathiesFING000010537.36
2285Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T223ECGA0002237.36
2286Coffee max likingGCST900947397.36
2287Omega-3 fatty acid levelsGCST905020557.36
2288CD40/TNFRSF14 ratioGCST903138307.35
2289PlateletcritGCST900024007.34
2290HMOX2/TDRKH ratioGCST903150677.34
2291Polyunsaturated fatty acids to total fatty acids percentageGCST905026337.34
2292Omega-6 fatty acids to omega-3 fatty acids ratioGCST904991947.33
2293IDP dMRI ProbtrackX ICVF cst rGCST900043847.32
2294IDP dMRI ProbtrackX L2 ifo rGCST900042867.32
2295Triglycerides in LDL (UKB data field 23409)GCST902695067.32
2296HBEGF levelsGCST904694337.32
2297DSG2 levelsGCST904278257.31
2298Linoleic acid levelsGCST905023067.31
2299Volume of left central nucleusGCST904749617.30
2300CLIP2/LAT2 ratioGCST903141287.30
2301PEAR1 levelsGCST904702047.29
2302AMBP/RARRES2 ratioGCST903132567.29
2303CDCP1/IL18BP ratioGCST903139377.29
2304Bone marrow fat fraction of thoracic vertebra 9GCST906523817.29
2305Cholesteryl Esters to Total Lipids in Large VLDL percentageGCST904981657.29
2306LAT/LYN ratioGCST903152837.28
2307Ptosis of eyelidFING000012277.27
2308Idiopathic goutFING000006587.27
2309Ulcerative colitis (strict definition, require KELA, min 2 HDR)FING000013887.27
2310Ceramide (d18:1/24:0) levelsGCST900240467.26
2311Fracture of upper limb (PheCode 803)GCST904762797.26
2312QC T1 inverse SNRGCST900063487.25
2313Omega-3 fatty acid levelsGCST905024367.25
2314CD79B/FCRL1 ratioGCST903138997.24
2315Liver volumeGCST905668187.23
2316HNRNPK/VASH1 ratioGCST903150717.22
2317ACY1 levelsGCST904682127.22
2318CCL4 levelsGCST904685837.21
2319Omega-3 fatty acid levelsGCST905024227.21
2320BTN2A1/LILRB4 ratioGCST903135467.21
2321CPM/LAMP2 ratioGCST903142157.21
2322LAYN/TNFRSF4 ratioGCST903152917.20
2323TINAGL1 levelsGCST904708737.20
2324MYH9 levelsGCST904699757.20
2325Volume of right medial nucleusGCST904750427.19
2326Glycosyl ceramide (d18:2/24:1, d18:1/24:2) levelsGCST902001187.19
2327BCAT1 levelsGCST904684277.19
2328PDGFA/SCARF1 ratioGCST903156177.19
2329ENO2/ITGB1BP2 ratioGCST903146617.17
2330Left-hemisphere visual network to left-hemisphere somatomotor network white-matter structural connectivityGCST903026497.17
2331Triglycerides in medium HDL (UKB data field 23571)GCST902696687.16
2332CD99/PIK3IP1 ratioGCST903139297.16
2333T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 74)GCST903206377.16
2334DNAJB1/SIRT2 ratioGCST903145117.16
2335Concentration of medium VLDL particles (UKB data field 23502)GCST902695997.15
2336Volume of left medial nucleusGCST904749767.15
2337SERPINE1 levelsGCST904705967.15
2338Degree of unsaturationGCST905022257.14
2339Principal component-derived dietary pattern 28GCST901330337.14
2340CCL17/GRK5 ratioGCST903136877.14
2341COMP/THBS4 ratioGCST903141937.12
2342total cholesterol (mean, inv-norm transformed)GCST904764247.12
2343Lupus erythematosusFING000007397.12
2344GALNT2 levelsGCST904692967.12
2345CLEC4D levelsGCST904687737.11
2346PODXL2 levelsGCST904702797.11
2347CD302 levelsGCST904686247.10
2348Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641)GCST902697387.10
2349F11R/SORT1 ratioGCST903147267.10
2350APP/PPP1R12A ratioGCST903133307.10
2351Total fatty acid levelsGCST905027227.10
2352Omega-6 fatty acids to total fatty acids percentageGCST905025287.10
2353Free cholesterol in small LDLGCST904996177.09
2354Saturated fatty acids levelsGCST905026757.09
2355Degree of unsaturationGCST905027377.08
2356Noninfectious disorders of lymphatic channels (PheCode 450)GCST904760027.08
2357CA2/NSFL1C ratioGCST903135807.08
2358ARHGAP1/SPARC ratioGCST903133447.08
2359Monounsaturated fatty acid levelsGCST905020367.08
2360Triglyceride levelsGCST902786457.07
2361RETN levelsGCST900120347.06
2362MAPRE3 levelsGCST904698597.05
2363Average diameter for LDL particlesGCST904984577.04
2364Cholesterol in Small HDLGCST904993487.03
2365Myocardial infarctionGCST900186577.03
2366APRT/EREG ratioGCST903133357.02
2367MGLL/PTPN6 ratioGCST903154407.02
2368ENPP6 levelsGCST904691177.02
2369Cardiac defibrillator in situ (PheCode 426.92)GCST904759617.02
2370Frailty (Factor 5 - Poorer Cognition)GCST906240517.01
2371CIAPIN1/SPARC ratioGCST903140697.01
2372Cholesterol to total lipids ratio in large VLDLGCST900928697.00
2373HAVCR2 levelsGCST904694327.00
2374Polyunsaturated fatty acids to total fatty acids percentage (UKB data field 23453)GCST902695507.00
2375N2-acetyl,N6,N6-dimethyllysine levelsGCST902006977.00
2376DYNLT1 levelsGCST904690576.99
2377PIGR levelsGCST904702326.99
2378Varicose veins of lower extremity, symptomtic (PheCode 454.11)GCST904760146.98
2379Microvirga abundance in stoolGCST900324796.98
2380ITGBL1 levelsGCST904696486.98
2381DepressionGCST0037696.98
2382KIR3DL1 levelsGCST904696876.97
2383Lymphocyte percentage of white cellsGCST0046326.97
2384CLEC1B/PPP1R2 ratioGCST903141016.97
2385SF3B4 levelsGCST904706096.97
2386Hippocampal subfield left CA3 volume (body)GCST902679406.96
2387KLK14 levelsGCST904697006.95
2388FUOM levelsGCST904692766.95
2389DTI TBSS L2 Superior fronto-occipital fasciculus RGCST903845186.95
2390LAMP3 levelsGCST904697356.95
2391EBI3_IL27/VCAM1 ratioGCST903145726.95
2392Plasma succinylcarnitine (C4-DC) levels in chronic kidney diseaseGCST902659986.95
2393Free cholesterol to total lipids ratio in medium VLDLGCST900929216.94
2394Sphingomyelin_41:0_[M+H]1+ levelsGCST900603866.94
2395CD40/GLOD4 ratioGCST903138146.94
2396HSPG2/PTGDS ratioGCST903150926.93
2397Other bacterial diseasesFING000009686.93
2398Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905024156.93
2399LAT/PLXNA4 ratioGCST903152866.93
2400L1CAM/SEZ6L ratioGCST903152666.93
2401GBP2 levelsGCST904693126.93
2402IPCEF1/SPARC ratioGCST903151866.93
2403Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)FING000008646.92
2404C-reactive protein levels (CRP.4337.49.2)GCST902405036.92
2405CLEC1B levelsGCST904687686.91
2406Cholesterol to total lipids ratio in very large HDLGCST900930056.91
2407TSPAN1 levelsGCST904709786.91
2408EDAR/LAT2 ratioGCST903145826.91
2409FGFBP1 levelsGCST904692306.91
2410Hippocampal right GC-ML-DG volume (head)GCST902679686.90
2411aseg rh intensity Accumbens-areaGCST900037886.89
2412EGFLAM levelsGCST904690846.89
2413ATOX1 levelsGCST904683856.88
2414Prevotella sp000434975 abundance in stoolGCST900325186.88
2415F-fatty/dairy food liking (derived food-liking factor)GCST900947606.87
2416CholelithiasisGCST900185996.86
2417TNF/TNFRSF1B ratioGCST903159426.86
2418Cholesteryl esters to total lipids ratio in small VLDLGCST900929716.85
2419LSP1 levelsGCST904698116.85
2420CNTN4 levelsGCST904688066.85
2421ACVRL1/TNFRSF19 ratioGCST903131596.85
2422ERBIN/SIRT2 ratioGCST903146966.84
2423TFPI2 levelsGCST904708386.84
2424Rosacea (PheCode 695.3)GCST904761786.83
2425CD99L2/CPM ratioGCST903139256.83
2426IL18BP/THBD ratioGCST903151566.82
2427Diastolic blood pressure x sex interactionGCST903351756.81
2428Alcohol use disorder, Swedish definitionFING000000536.81
2429Myo-inositol levelsGCST902435276.80
2430CD69/CLEC1B ratioGCST903138696.79
2431Plasma pregnenetriol sulfate* levels in chronic kidney diseaseGCST902658666.79
2432Acetate levelsGCST900928036.79
2433Cholesterol levels in very small VLDLGCST905007126.78
2434NPY levelsGCST904700816.78
2435wg rh intensity-contrast superiortemporalGCST900038566.77
2436FLI1 levelsGCST904692476.77
2437CEACAM6 levelsGCST904686976.76
2438PDGFA levelsGCST904701886.76
2439COL6A3/SMOC2 ratioGCST903141786.76
2440Ovarian dysfunctionFING000011336.76
2441MAP2K6/TBL1X ratioGCST903153786.74
2442IDP dMRI TBSS ICVF Superior cerebellar peduncle RGCST900043396.72
2443Docosahexaenoic acid levelsGCST905022436.72
2444NMI levelsGCST904700566.72
2445TMSB10/TXNRD1 ratioGCST903159256.71
2446DPY30 levelsGCST904690376.71
2447FUCA1 levelsGCST904692756.71
2448Abdominal and pelvic pain | Symptoms and signs involving the digestive system and abdomenUKBB000000016.71
2449Monounsaturated fatty acid levelsGCST905023476.71
2450Testicular hypofunction (PheCode 257.1)GCST904756976.71
2451Recent feelings of foreboding | AnxietyUKBB000007386.71
2452MANF/PRDX5 ratioGCST903153656.70
2453Disorders of iron metabolism (PheCode 275.1)GCST904757436.70
2454F-dairy liking (derived food-liking factor)GCST900947516.69
2455CFHR5 levelsGCST904687286.68
2456Cholesterol to total lipids ratio in chylomicrons and extremely large VLDLGCST900930416.67
2457HGFAC levelsGCST904694486.67
2458GP6/SCARF1 ratioGCST903149696.67
2459Triglycerides to total lipids ratio in large VLDLGCST900928796.67
2460X-21286 levelsGCST902005626.67
2461Triglycerides in small LDLGCST904997226.66
2462PAG1 levelsGCST904701476.66
2463DNER levelsGCST904690196.65
2464Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587)GCST902696846.65
2465Epiandrosterone sulfate levelsGCST901997526.64
2466TIMP3 levelsGCST904708716.64
2467Docosahexaenoic acid levelsGCST905022546.64
2468GUSB levelsGCST904694216.64
2469CCL5 levelsGCST904685846.64
2470CCN1/DNAJB1 ratioGCST903137096.64
2471CCL5/CXCL3 ratioGCST903137006.64
2472Omega-3 fatty acid levelsGCST905024416.63
2473IDP dMRI ProbtrackX L1 unc lGCST900042716.63
2474GP1BA/SDC4 ratioGCST903149576.63
2475VTA1 levelsGCST904710586.63
2476Concentration of VLDL particles (UKB data field 23428)GCST902695256.61
2477IDP T1 FAST ROIs R putamenGCST900025526.59
2478Cholesteryl esters in very large VLDLGCST905005566.59
2479Curry likingGCST900947506.58
2480VCAN levelsGCST904710326.58
2481CLEC4G/LGALS4 ratioGCST903141206.58
2482TCL1A/TNFRSF13C ratioGCST903159126.57
2483AHSP/HMBS ratioGCST903132176.57
2484IDP dMRI TBSS FA Posterior thalamic radiation RGCST900039056.57
2485Triglyceride levels in large LDLGCST900928666.56
2486Cardiorespiratory fitness slopeGCST900933196.56
2487CASP3/SERPINB9 ratioGCST903136426.56
2488aseg lh intensity Accumbens-areaGCST900037746.54
2489X-11786--methylcysteine levelsGCST902436546.54
2490Docosahexaenoic acid to total fatty acids percentageGCST905022846.54
2491rfMRI amplitudes (ICA100 node 27)GCST900046156.54
2492Unspecified dementiaFING000014006.53
2493Tonsillectomy and adenotomyFING000013676.53
2494MYOC/RGMB ratioGCST903155086.53
2495ATF6 levelsGCST902408166.53
2496EIF4B/MAP4K5 ratioGCST903146236.52
2497FCRL1 levelsGCST904692056.52
2498CTSZ levelsGCST904689186.52
2499P4HB/PPP1R12A ratioGCST903155916.52
2500CRISP3 levelsGCST904688666.52
2501Triglyceride levels in medium HDLGCST900929026.52
2502Total cholesterol levelsGCST902786446.52
2503Free cholesterol to total lipids ratio in medium LDLGCST900929096.51
2504MAVS/PPP1R9B ratioGCST903153936.51
2505Polyunsaturated fatty acids to total fatty acids percentageGCST905021796.50
2506PTGR1 levelsGCST904703706.49
2507ICD10 O42: Premature rupture of membranesGCST904542386.48
2508AmygNuclei rh volume Central-nucleusGCST900026626.48
2509DBI/MESD ratioGCST903144096.48
2510NIT1 levelsGCST904700506.48
2511NPPC levelsGCST904700756.47
2512Conductive hearing loss (PheCode 389.2)GCST904759126.47
2513CRELD2/TXNDC5 ratioGCST903142596.46
2514Linoleic acid to total fatty acids percentageGCST905020176.46
2515FOXO1/SNAP23 ratioGCST903148756.46
2516ABHD14B/CCS ratioGCST903131396.46
2517DDAH1 levelsGCST904689666.45
2518X-24406 metabolite levelGCST906167896.45
2519Cholesterol in Medium LDLGCST904987076.45
2520White blood cell count (basophil)GCST0046186.44
2521IFNG levelsGCST904695156.44
2522IL1RAP levelsGCST904695736.44
2523CDKN1A/PLA2G4A ratioGCST903139746.44
2524IL1B levelsGCST904695706.42
2525Docosahexaenoic acid levelsGCST905022596.42
2526ANG/RARRES2 ratioGCST903132716.42
2527Non-seminoma of testis, excluding all cancers (controls excluding all cancers)FING000008746.42
2528Honey likingGCST900947826.42
2529CDKN1A/HBEGF ratioGCST903139726.41
2530KDR levelsGCST904696726.41
2531Cholesteryl Esters in IDLGCST904975236.41
2532PCSK9 levelsGCST904701776.40
2533PZP levelsGCST904703996.39
2534Platelet crit (UKB data field 30090)GCST904680966.39
2535ALCAM/CNTN1 ratioGCST903132356.39
2536F-highly palatable foods liking (derived food-liking factor)GCST900947856.39
2537EIF3J levelsGCST902411226.39
2538FUT8/SORT1 ratioGCST903148926.38
2539EGFR levelsGCST904690856.38
2540Triglyceride levels in IDLGCST900928416.38
2541SPARCL1 levelsGCST902428706.37
2542Familial combined hyperlipidemia defined by Brunzell criteriaGCST901040036.36
2543Mean corpuscular hemoglobinGCST900023236.36
2544Concentration of VLDL particlesGCST900930006.36
2545Prescriptions - sulfonylurea|diabetesUKBB000007036.36
2546Chronic sinusitis (PheCode 475)GCST904760206.36
2547IDP dMRI ProbtrackX L2 ifo lGCST900042856.35
2548Secondary hypothyroidism (PheCode 244.1)GCST904756496.35
2549CALCOCO1/CASP3 ratioGCST903135966.34
2550T1 CAT volume L VIIIbGCST903841306.33
2551HYOU1/RARRES2 ratioGCST903151036.33
2552CLEC6A levelsGCST904687776.33
2553CCL5/LAMA4 ratioGCST903137036.33
2554Cholelithiasis | digestiveUKBB000001316.33
2555COL5A1 levelsGCST904688206.32
2556C36:4 Phosphatidylethanolamine levels in chronic kidney diseaseGCST902573576.32
2557aseg rh volume AmygdalaGCST900026426.32
2558CXCL17 levelsGCST904689296.32
2559PFKFB2/SRP14 ratioGCST903156506.32
2560EZR levelsGCST904691626.32
2561HDGF levelsGCST904694426.31
2562EPHB6/TNFRSF9 ratioGCST903146826.31
2563APOM/ERBB3 ratioGCST903133146.30
2564Fractured bone site(s) - Wrist | Medical conditionsUKBB000002576.30
2565BIN2/EREG ratioGCST903135036.30
2566aparc-a2009s rh volume S-oc-middle+LunatusGCST900030556.30
2567Lymphocyte percentage (UKB data field 30180)GCST904680836.29
2568CCN2/EDAR ratioGCST903137116.29
2569PHYKPL levelsGCST904702286.29
2570MITD1/WWP2 ratioGCST903154586.29
2571ATRN levelsGCST904684006.28
2572Phosphatidylethanolamine (18:0_18:1) levelsGCST900249776.28
2573Allergic conjunctivitisFING000000676.28
2574CERT levelsGCST904687176.28
2575Phospholipids to total lipids in large VLDL percentage (UKB data field 23589)GCST902696866.26
2576Alkylphosphatidylcholine (O-34:1) levelsGCST900249256.26
2577C8 Carnitine levels in chronic kidney diseaseGCST902576806.26
2578SSC5D levelsGCST904707486.25
2579total cholesterol (minimum, inv-norm transformed)GCST904764276.25
2580Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T229ECGU0002296.25
2581Sleep disorders | neurologicalUKBB000007766.25
2582Plasma 4-guanidinobutanoate levels in chronic kidney diseaseGCST902646206.24
2583GDNF levelsGCST904693236.24
2584CDKN1A/ENO2 ratioGCST903139696.24
2585PMVK levelsGCST904702726.24
2586DTI TBSS L2 Superior cerebellar peduncle RGCST903844886.24
2587F2R/ITGB1BP2 ratioGCST903147316.23
2588Saturated fatty acids levelsGCST905026746.23
2589KLK6 levelsGCST904697056.22
2590TTR levelsGCST904709856.22
2591BSG/IL12A_IL12B ratioGCST903135326.21
2592Milk type used - Full cream | DietUKBB000004686.21
2593CD69/SCARF1 ratioGCST903138856.21
2594RAB6A levelsGCST904704126.19
2595DKK1/SERPINE1 ratioGCST903144806.18
2596Omega-3 fatty acid levelsGCST905020646.18
2597wg lh intensity-contrast lateralorbitofrontalGCST900038036.18
2598Omega-6 fatty acids levelsGCST904991776.18
2599Other and unspecified tonsillitisFING000009546.18
2600CA1/CA3 ratioGCST903135726.17
2601HBEGF/PDGFA ratioGCST903150336.17
2602Cholesterol to total lipids in small LDL percentage (UKB data field 23625)GCST902697226.17
2603Synovitis and tenosynovitis (PheCode 727.1)GCST904762426.17
2604CD74 levelsGCST904686476.16
2605PRELP levelsGCST904703216.16
2606EDAR/SDC4 ratioGCST903145856.16
2607IDP dMRI TBSS L1 Retrolenticular part of internal capsule LGCST900040966.16
2608SNX18 levelsGCST904707006.16
2609CILP levelsGCST904687546.15
2610HCLS1 levelsGCST904694376.14
2611ATOX1/TMSB10 ratioGCST903133776.14
2612Free cholesterol in small HDLGCST904994116.14
2613SOST levelsGCST904707116.14
2614HAVCR1 levelsGCST904694316.14
2615CRELD1 levelsGCST904688586.13
2616PDGFB/PRKAR1A ratioGCST903156246.13
2617Acetone levelsGCST900928056.13
2618GFER/TRIAP1 ratioGCST903149216.12
2619Bone marrow fat fraction of thoracic vertebra 11GCST906523836.12
2620Cholesterol to total lipids ratio in medium LDLGCST900929056.12
2621Linoleic acid levelsGCST905020106.11
2622T1 CAT volume L IXGCST903841336.11
2623IDP dMRI TBSS MO Medial lemniscus RGCST900039606.11
2624KIFBP/LYN ratioGCST903152466.11
2625NSFL1C/RILP ratioGCST903155606.10
2626CD274 levelsGCST904686136.10
2627Loneliness (standard GWA)GCST902672886.09
2628Triglycerides to total lipids ratio in IDLGCST900928426.08
2629IDP dMRI ProbtrackX L3 cst lGCST900043086.07
2630CLEC4C levelsGCST904687726.07
2631FSTL1 levelsGCST904692716.07
2632Triglycerides to total lipids in very small VLDL percentage (UKB data field 23608)GCST902697056.07
2633IDP dMRI TBSS MD Sagittal stratum LGCST900040586.07
2634FCRL1/TCL1A ratioGCST903147956.06
2635Concentration of medium VLDL particlesGCST900929236.06
2636FCER2 levelsGCST904691996.06
2637ADAM23 levelsGCST902409226.05
2638S100A11 levelsGCST904705126.05
2639BCR/NFATC1 ratioGCST903134966.05
2640Small cell lung carcinomaGCST0047466.05
2641Percentage of M9 (GP18)GCST906684626.04
2642OSCAR levelsGCST904701316.04
2643SERPINA3 levelsGCST904705836.04
2644Loneliness (weighted GWA)GCST902672896.04
2645CD58/TYRO3 ratioGCST903138566.03
2646mean platelet volume (MPV, maximum, inv-norm transformed)GCST904755176.03
2647Chronic obstructive pulmonary disease in never smokersGCST900165896.02
2648Plasma 11beta-hydroxyandrosterone glucuronide levels in chronic kidney diseaseGCST902643216.02
2649Lignoceroylcarnitine (C24) levelsGCST902001376.02
2650C2 levelsGCST904684976.02
2651Left-hemisphere dorsal attention network to putamen white-matter structural connectivityGCST903027036.01
2652Saturated fatty acids levelsGCST905021926.01
2653Omega-6 fatty acid levelsGCST905025146.01
2654wg rh intensity-contrast fusiformGCST900038336.00
2655Burger likingGCST900947156.00
2656Mean platelet volume at deliveryGCST903022325.99
2657Interpolated Age of participant when operation took place | OperationsUKBB000003705.99
2658CD19 on IgD- CD38- B cellGCST900017335.99
2659Total fatty acid levelsGCST905022185.99
2660IDP dMRI TBSS MD Pontine crossing tractGCST900040285.99
2661SERPINI1 levelsGCST904706025.99
2662Operative procedures - Total cholecystectomy NEC | Summary OperationsUKBB000005895.98
2663IL16/NADK ratioGCST903151525.97
2664ECM1 levelsGCST904690655.97
2665CXCL16 levelsGCST902405245.96
2666MAX levelsGCST904698675.96
2667Physical activity (Total log acceleration 8pm-10pm)GCST900614195.96
2668FYB1/MESD ratioGCST903149115.96
2669Primary biliary cholangitis (PBC)FING000012115.96
2670SH3BP1 levelsGCST904706195.95
2671DNAJB1/METAP2 ratioGCST903145095.95
2672Physical activityGCST900933225.95
2673CC2D1A/TMSB10 ratioGCST903136675.95
2674Cholesterol to total lipids in very small VLDL percentage (UKB data field 23605)GCST902697025.94
2675ENO2/PRSS27 ratioGCST903146665.94
2676Acetate levels (UKB data field 23475)GCST902695725.94
2677MigraineGCST904681425.93
2678Alzheimer's disease (MTAG)GCST904490555.93
2679Gouty arthropathy (PheCode 274.11)GCST904757385.93
2680SIGLEC1/SSC5D ratioGCST903158445.93
2681Lysoalkylphosphatidylcholine (O-24:2) levelsGCST900254385.93
2682MEGF10 levelsGCST904698825.93
2683Alkenylphosphatidylethanolamine (P-20:0/18:2) levelsGCST900256835.92
2684ITGB7 levelsGCST904696475.91
2685Mean platelet volume during the postpartum periodGCST903022335.91
2686Low density lipoprotein cholesterol levelsGCST900024125.90
2687Alkylphosphatidylcholine (O-16:0/16:0) levelsGCST900249135.90
2688Phospholipid levels in very large HDLGCST901326425.90
2689Alkenylphosphatidylcholine (P-36:3) levelsGCST900249545.90
2690Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452)GCST902695495.89
2691ALB/Globulin ratioUKBB000000205.89
2692Phosphatidylcholine-O_40:5_[M+H]1+/Phosphatidylcholine-P_40:4_[M+H]1+ levelsGCST900604235.89
2693Free cholesterol to total lipids ratio in large VLDLGCST900928735.88
2694Verbal-numerical reasoningGCST0034985.88
2695SUSD5 levelsGCST904707895.88
2696Clinical anxiety and depression (confirmatory factor analysis Factor 3)GCST903093385.88
2697CASP3/MESD ratioGCST903136365.87
2698TOP2B levelsGCST904709345.87
2699FYB1/PDGFB ratioGCST903149125.86
2700AIFM1 levelsGCST904682685.86
2701Pain type(s) experienced in last month - Neck or shoulder pain | PainUKBB000006305.85
2702ADAMTS4 levelsGCST904682265.85
2703GGH levelsGCST904693355.85
2704Total Ceramide levelsGCST900245785.84
2705aparc-DKTatlas rh volume parsopercularisGCST900029095.83
2706SEMA4D levelsGCST904705735.83
2707Docosahexaenoic acid levelsGCST905022585.83
2708HSPB1/PLIN3 ratioGCST903150885.82
270921-hydroxypregnenolone disulfate levelsGCST901998495.82
2710IDP T1 FAST ROIs V cerebellum XGCST900025885.82
2711RARRES2/ST6GAL1 ratioGCST903157595.82
2712PLAU/PLAUR ratioGCST903156745.81
2713NOTCH3 levelsGCST904700675.81
2714MFAP5 levelsGCST904698995.81
2715Prevotellamassilia abundance in stoolGCST900325175.80
2716Osteoporosis (PheCode 743.1)GCST904762595.80
2717EDAR/SPARC ratioGCST903145885.79
2718AGRP levelsGCST902402175.79
2719F2R/MPIG6B ratioGCST903147325.79
2720DAG1/HBEGF ratioGCST903143765.77
2721Cholesterol levels in very large VLDLGCST905005175.77
2722Sleep disorders | Episodic and paroxysmal disordersUKBB000007755.76
2723XRCC4 levelsGCST904710855.76
2724IL12RB1 levelsGCST904695505.76
2725CNTNAP2 levelsGCST904688085.75
2726GSTA3/KRT18 ratioGCST903149975.74
2727PPP1R12A/SPARC ratioGCST903157125.74
2728F-healthy food liking (derived food-liking factor)GCST900947795.74
2729PLB1 levelsGCST904702535.74
2730Omega-6 fatty acids to total fatty acids percentageGCST905025405.74
2731B4GALT1/SMOC2 ratioGCST903134335.73
2732ECG, heart rate | ECG during exerciseUKBB000002045.73
2733IDP T1 FAST ROIs L cerebellum crus IIGCST900025725.73
2734DKK1/SDC4 ratioGCST903144795.72
2735CDKN1A levelsGCST904686845.72
2736TMSB10/TRIAP1 ratioGCST903159245.72
2737total cholesterol (maximum, inv-norm transformed)GCST904764205.72
2738MPIG6B/PLXNA4 ratioGCST903154835.71
2739ANXA1 levelsGCST902402965.70
2740Main speciality of consultant (recoded) - Gastroenterology | Summary AdministrationUKBB000004155.69
2741ESYT2 levelsGCST904691565.69
2742CD74/DLL1 ratioGCST903138915.68
2743RASSF2 levelsGCST904704315.68
2744Chronic ulcer of skin (PheCode 707)GCST904762165.68
2745Platelet distribution width (UKB data field 30110)GCST904680975.68
2746HMCN2 levelsGCST904694615.68
2747Mean platelet volumeGCST0045995.67
2748IDP dMRI TBSS L3 Cingulum hippocampus LGCST900042085.67
2749LY75 levelsGCST904698225.67
2750ADAMTS8/FAP ratioGCST903131725.66
2751NOTCH1/SEMA7A ratioGCST903155455.66
2752CST6/GAL ratioGCST903143025.66
2753Birth weight known - No | Early life factorsUKBB000000965.66
2754Omega-3 fatty acids to total fatty acids percentageGCST905020825.65
2755SNX2 levelsGCST904707015.65
2756ACE2 levelsGCST904681975.65
2757CD74/IL18BP ratioGCST903138925.64
2758Glycated haemoglobin (HbA1c) | Blood biochemistryUKBB000002895.63
2759Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020775.63
2760DLL1/IL18BP ratioGCST903144955.63
2761Saturated fatty acids to total fatty acids percentageGCST905022075.63
2762FKBP5/TBCC ratioGCST903148495.63
2763Glycosyl ceramide (d18:1/20:0, d16:1/22:0) levelsGCST902001455.62
2764CXCL5/EDAR ratioGCST903143495.62
2765Cholesteryl esters to total lipids in medium LDL percentage (UKB data field 23621)GCST902697185.62
2766CASP8/PRDX6 ratioGCST903136555.61
2767FCRL1/TNFRSF13C ratioGCST903147965.61
2768Bone marrow fat fraction of lumbar vertebra 1GCST906523865.61
2769ADAMTS15 levelsGCST904682235.60
2770SLAMF7/TXNDC15 ratioGCST903158505.60
2771Volume of right cortical nucleusGCST904750305.60
2772Percentage of trisyalated structures in total plasma glycans (GP97)GCST906685415.59
2773CNST levelsGCST904688015.59
2774MAP4K5/TBCC ratioGCST903153855.59
2775Sulcal opening distance of the right calloso-marginal posterior fissureGCST901049465.58
2776Chronic obstructive pulmonary disease x ever smoker interaction (main effect)GCST900165865.57
2777Platelet countGCST0046035.57
2778Left eye overall retinal pigment epithelium thicknessGCST906720325.57
2779Omega-3 fatty acids to total fatty acids percentageGCST905020905.56
2780CTBS levelsGCST904689005.56
2781T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 47)GCST903206105.56
2782IDP dMRI ProbtrackX FA ptr rGCST900039455.56
2783GZMA levelsGCST904694235.56
2784Omega-3 fatty acids to total fatty acids percentageGCST905024675.55
2785AZU1/CEACAM8 ratioGCST903134245.55
2786LTBP2/MYOC ratioGCST903153375.55
2787SNAP29/TJAP1 ratioGCST903158615.54
2788Doctor diagnosed hayfever or allergic rhinitis | Medical informationUKBB000001925.54
2789Activities undertaken to treat depression | DepressionUKBB000000105.54
2790CHMP1A/EREG ratioGCST903140485.53
2791Number of operations, self-reported | OperationsUKBB000005395.52
2792Citrate levelsGCST904972005.51
2793Triacylglycerol_47:4_[M+NH4]1+ levelsGCST900603915.51
2794DTI TBSS L1 Splenium of corpus callosumGCST903844325.51
2795KLK11 levelsGCST900120125.50
2796CD300LG/CD93 ratioGCST903138005.50
2797GZMA/TNFRSF4 ratioGCST903150135.50
2798Androstenediol (3beta,17beta) disulfate (1) levelsGCST901998425.50
2799CD99/KITLG ratioGCST903139245.50
2800Inflammatory markers and poor diet (confirmatory factor analysis Factor 30)GCST903093645.49
2801Inflammatory bowel disease and other gasteroenteritis and colitis (PheCode 555)GCST904760655.49
2802Cholesteryl Esters in Large VLDLGCST904981545.49
2803NINJ1 levelsGCST904700495.49
2804platelet count (minimum, inv-norm transformed)GCST904763025.48
2805MSMB levelsGCST904699495.48
2806Phospholipids in large HDLGCST904978535.47
2807CDH2/SSC4D ratioGCST903139515.47
2808Triglycerides in large LDLGCST904980765.46
2809PFKFB2 levelsGCST904702155.46
2810Cholesterol to total lipids ratio in very large VLDLGCST900930175.46
2811Basal cell carcinomaGCST904681145.45
2812APP/DAG1 ratioGCST903133205.45
2813Bifidobacterium kashiwanohense abundance in stoolGCST900322265.45
2814Primary sclerosing cholangitisGCST0040305.44
2815DTI TBSS L3 Splenium of corpus callosumGCST903845285.44
2816CNST/ITGB1BP2 ratioGCST903141585.43
2817IDP dMRI TBSS L3 Posterior thalamic radiation RGCST900041995.43
2818EDAR/ITGB1BP2 ratioGCST903145805.42
2819DPP10 levelsGCST904690325.42
2820BIN1 levelsGCST900907575.42
2821Ever suffered mental distress preventing usual activities | Mental distressUKBB000002235.41
2822F-fatty/salty food liking (derived food-liking factor)GCST900947595.40
2823DAB2/ERBIN ratioGCST903143615.40
2824EDIL3 levelsGCST904690725.40
2825IDP dMRI TBSS ICVF Posterior corona radiata RGCST900043535.40
2826AKR7L levelsGCST904682755.40
2827Modified Stumvoll Insulin Sensitivity Index (adjusted for BMI)GCST902675735.40
2828KEL levelsGCST904696735.39
2829FURIN/IGSF3 ratioGCST903148855.39
2830CXCL11 levelsGCST904689245.39
2831FCRL2/KLB ratioGCST903147985.38
2832NFKB1 levelsGCST904700375.38
2833Free cholesterol to total lipids ratio in small VLDLGCST900929735.38
2834ANXA3/SERPINB1 ratioGCST903132895.37
2835Mean platelet thrombocyte volume (UKB data field 30100)GCST904680875.37
2836Myasthenia gravisGCST900930615.37
2837AK1/PEBP1 ratioGCST903132255.37
2838CXCL6 levelsGCST904689335.37
2839CD200/CLEC4G ratioGCST903137465.37
2840TCN2 levelsGCST904708205.37
2841TFRC levelsGCST904516845.36
2842IDP dMRI ProbtrackX ICVF fmiGCST900043865.36
2843GALNT10/TNFSF12 ratioGCST903149165.35
2844NPTXR levelsGCST904700805.35
2845SCARA3 levelsGCST904278565.35
2846Saturated fatty acids to total fatty acids percentageGCST904999585.35
2847IDP dMRI TBSS L2 Sagittal stratum LGCST900041545.35
2848Vitamin and mineral supplements - Multivitamins +/- minerals | MedicationUKBB000009005.34
2849CA4 levelsGCST904685135.34
2850HBEGF/YES1 ratioGCST903150395.34
2851VAMP8 levelsGCST904710255.34
2852Polyunsaturated fatty acids to total fatty acids percentageGCST905026455.33
2853ARHGEF12/DECR1 ratioGCST903133495.33
2854SSH3 levelsGCST904707495.32
2855IDP T1 FIRST left pallidum volumeGCST900024425.32
2856wg lh intensity-contrast temporalpoleGCST900038245.31
2857Ribothymidine levels in chronic kidney diseaseGCST902575545.31
2858F-deep fried food liking (derived food-liking factor)GCST900947535.31
2859GZMH/KLRD1 ratioGCST903150165.30
2860CLIP2/DNAJA2 ratioGCST903141275.30
2861Seborrhoeic dermatitisFING000012825.30
2862F9/RARRES2 ratioGCST903147495.30
2863PDGFB/PPP1R12A ratioGCST903156235.30
2864aparc-a2009s rh area S-centralGCST900034155.30
2865Triglycerides to total lipids ratio in very large VLDLGCST900930275.29
2866DTI TBSS MD Sagittal stratum LGCST903846035.29
2867CRIM1 levelsGCST904688635.29
2868Phospholipids to total lipids in medium LDL percentage (UKB data field 23619)GCST902697165.29
2869IDP dMRI ProbtrackX L3 fmiGCST900043115.29
2870Polyunsaturated fatty acid levelsGCST905026235.29
2871PKLR/UBAC1 ratioGCST903156605.29
2872CA4/PECAM1 ratioGCST903135865.29
2873Cholesterol to total lipids ratio in small VLDLGCST900929695.29
2874Otitis media (PheCode 381.1)GCST904759035.29
2875IL34 levelsGCST904695935.28
2876BLVRB/CA1 ratioGCST903135215.28
2877Maximum indexed left atrial volumeGCST900190125.28
2878MAVS/TBL1X ratioGCST903153995.28
2879Hypercalcemia (PheCode 275.6)GCST904757485.27
2880Polyunsaturated fatty acid levelsGCST904992715.27
2881PRTG levelsGCST904703475.27
2882TREH levelsGCST904709595.27
2883PPP1R2/TBL1X ratioGCST903157205.27
2884Age hay fever, rhinitis or eczema diagnosed | Medical conditionsUKBB000000155.27
2885Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596)GCST902696935.27
2886Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622)GCST902697195.26
2887Free cholesterol to total lipids ratio in small HDLGCST900929495.26
2888CXCL9 levelsGCST902747845.26
2889EDAR/PSRC1 ratioGCST903145845.26
2890IDP dMRI ProbtrackX L1 fmiGCST900042575.26
2891Phospholipids to total lipids ratio in very large VLDLGCST900930255.25
2892Linoleic acid to total fatty acids percentageGCST905023325.25
2893CD38/IL12A_IL12B ratioGCST903138085.25
2894AIFM1/PLXNA4 ratioGCST903132205.24
2895Acquired hypothyroidism (PheCode 244.2)GCST904756505.24
2896Body mass indexGCST901037515.24
2897wg rh intensity-contrast inferiortemporalGCST900038355.24
2898IGF1R levelsGCST904695245.24
2899PTPRM levelsGCST904703845.23
2900Cholesteryl esters to total lipids in very large HDL percentage (UKB data field 23631)GCST902697285.23
2901CSF1 levelsGCST904688815.23
2902DTI TBSS MD Splenium of corpus callosumGCST903845765.23
2903ERMAP levelsGCST904691475.22
2904Total fatty acid levelsGCST905000535.22
2905VEGFB levelsGCST904710355.22
2906CC2D1A/STIP1 ratioGCST903136655.22
2907IDP dMRI TBSS MO Retrolenticular part of internal capsule RGCST900039725.21
2908Low hand grip strength (60 years and older) (FNIH)GCST900075295.21
2909F-cheese liking (derived food-liking factor)GCST900947295.21
2910wg rh intensity-contrast lingualGCST900038395.21
2911F12 levelsGCST904691665.21
2912SNX5 levelsGCST904707025.20
2913X-14626 levelsGCST902438615.19
2914CLEC1B/LGALS8 ratioGCST903140965.19
2915Cholesterol in Large LDLGCST904979235.19
2916Comorbidity of gastric and duodenal ulcersGCST902709295.19
2917FCRLB levelsGCST904692105.19
29181-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) levelsGCST902000835.19
2919CD5L levelsGCST904686405.18
2920Liver volumeGCST900166665.18
2921LDL direct, adjusted by medication | Lipid or lipoprotein measurementUKBB000003875.18
2922Central pulse pressureGCST902673875.18
2923ASGR2 levelsGCST904683765.17
2924Placental weight (paternal genotype, adjusted for sex and gestational age)GCST902751915.17
2925Other diseases of upper respiratory tractFING000010125.16
2926NPHS1 levelsGCST904700705.16
2927Phospholipids in medium VLDL (UKB data field 23504)GCST902696015.16
2928CX3CL1/EPHB6 ratioGCST903143245.16
2929GZMA/IL12A_IL12B ratioGCST903150095.16
2930IL12A_IL12B/LAG3 ratioGCST903151475.15
2931CRTAP levelsGCST904688725.15
2932Bone marrow fat fraction of thoracic vertebra 12GCST906523845.14
2933aseg rh intensity Cerebellum-CortexGCST900037815.13
2934REST UKBBICA NODEamps25 0006GCST903854895.13
2935Triglycerides in very small VLDLGCST905008735.13
2936Metabolic syndromeGCST904444895.13
2937SIAE/SNAP29 ratioGCST903158435.13
2938Heart failure and bmi 25plusFING000006035.13
2939Chronic lung diseases including COPD, Emphysema and BronchitisGCST904752725.13
2940ROR1/TNFRSF21 ratioGCST903157875.11
2941HYOU1/THBD ratioGCST903151065.10
2942SERPINA4 levelsGCST904705845.10
2943Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T313ECGU0003135.10
2944Cardiac conduction disorders (PheCode 426)GCST904759525.10
2945Saturated fatty acids levelsGCST904999535.09
29461-stearoyl-gpc (18:0) levelsGCST901997325.09
2947ANXA3/HCLS1 ratioGCST903132825.09
2948Birth weight known - Yes - pounds and ounces | Early life factorsUKBB000000975.09
2949DDR1 levelsGCST904689705.07
2950AHNAK levelsGCST904682615.07
2951Cholesteryl esters to total lipids ratio in medium LDLGCST900929075.07
2952F9/PROC ratioGCST903147485.07
2953IDP dMRI TBSS L3 Posterior corona radiata LGCST900041985.06
2954Omega-3 fatty acids to total fatty acids percentageGCST905024515.06
2955DTI TBSS MD Anterior corona radiata RGCST903845945.06
2956TCL1A levelsGCST904708175.05
2957FLT1 levelsGCST904692495.05
2958TNFRSF13C/TNFSF13B ratioGCST903159345.05
2959DKK1/ZBTB16 ratioGCST903144865.04
2960IDP dMRI TBSS ICVF Anterior limb of internal capsule RGCST900043435.04
2961aparc-a2009s rh thickness Pole-temporalGCST900037195.03
2962Urine taurodeoxycholic acid 3-sulfate levels in chronic kidney diseaseGCST902660455.02
2963IFNGR1/THBD ratioGCST903151305.02
2964DTI autoptx FA str r tractGCST903851365.01
2965Salad leaves likingGCST900948235.01
2966PCBD1 levelsGCST904701665.01
2967CHL1 levelsGCST904687455.01
2968CTSZ/NAAA ratioGCST903143205.00
2969Bone marrow fat fraction of lumbar vertebra 5GCST906523905.00
2970aseg lh intensity PutamenGCST900037705.00
2971Polyunsaturated fatty acids to total fatty acids percentageGCST905026444.99
2972Volume of left whole amygdalaGCST904749864.99
2973TIRAP levelsGCST902430324.99
2974wg lh intensity-contrast parstriangularisGCST900038114.99
2975SPINT1 levelsGCST902417174.98
2976Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T228ECGU0002284.98
2977CA9 levelsGCST904685184.98
2978BA-exvivo rh area BA4pGCST900032264.97
2979TSC1 levelsGCST904709724.96
2980CASP10 levelsGCST904685424.96
2981CD69/CEP43 ratioGCST903138674.96
2982CD69/PPP1R2 ratioGCST903138824.96
2983LBR/POLR2F ratioGCST903152974.96
2984FADD/PPP1R2 ratioGCST903147744.96
2985Linoleic acid levelsGCST905023104.95
2986CCN2 levelsGCST904685884.95
2987ADH4/SCLY ratioGCST903131954.95
2988Triglycerides to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23583)GCST902696804.95
2989TNFRSF11B levelsGCST900120024.95
2990Free cholesterol to total lipids in IDL percentage (UKB data field 23612)GCST902697094.94
2991AKT1S1 levelsGCST904682764.94
2992wg rh intensity-contrast parahippocampalGCST900038424.93
2993IDP dMRI ProbtrackX ICVF cgh lGCST900043814.93
2994Lymphocyte countGCST900023164.93
2995CDHR2/SSC4D ratioGCST903139654.92
2996CCL13/CCL2 ratioGCST903136754.91
2997Number of days/week walked 10+ minutes | Physical activityUKBB000005354.91
2998COLEC12/TAFA5 ratioGCST903141854.91
2999AXIN1/GOPC ratioGCST903134074.91
3000FOXO1/NFATC1 ratioGCST903148734.91